Sufentanil transdermal patch (宜昌人福)

舒芬太尼透皮贴剂 (宜昌人福)

Report date: 2026/05/26 20:00:28

Base Information

Drug NameSufentanil transdermal patch (宜昌人福)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsδ-opioid receptor agonistsKappa opioid receptor agonists
TargetsMu opioid receptorδ-opioid receptorKappa opioid receptor
Therapy Area/IndicationsChronic PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYichang Humanwell Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsChronic PainPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A